Search

Objectives: The aim of this study was to review the demographic and clinicopathological findings of the patients who underwent prophylactic or therapeutic parotidectomy due to the secondary neoplasm of the parotid gland (SNP), the outcomes of the patients with SNP and to provide a perspective to the parotid and neck approach in head and neck skin cancer cases. Methods: The clinical data of 178 patients who underwent parotidectomydue to neoplasm in the Department of Otorhinolaryngology, Head and Neck Surgery of a tertiary referral center from 2012 to 2017 were reviewed. Results: Among 178 patients, twenty-two (12.4%) patients were found to underwentprophylactic or therapeutic parotidectomy due to SNP. Six of these patients had pathologically positive parotid metastases (therapeutic parotidectomy). The median age of six patients was 67 years (ranging from 2 to 83 years). Five patients were male and one was female. The most common indication of parotidectomy (prophylactic and therapeutic) and pathology of parotid mass due to SNP and Cutaneous Squamous Cell Carcinoma (SCC) (36.3% and 50%, respectively). Conclusions: Owing to rapidly progressive feature and high morbidity, close observation of parotid in case of metastasis is crucial for recurrent SCC of the face and scalp.

Aim: Salivary gland tumors (SGTs) are rare neoplasms thus, the local records are valuable to obtain the epidemiological overview. This study aimed to determine the demographic and clinicopathological features of SGTs in our clinic and compare the findings with the studies from Turkey and all over the world.Material and methods: The data of 185 patients who underwent surgery for SGT in The Department of Otorhinolaryngology-Head and Neck Surgery of a tertiary referral center between 2012 and 2017 were studied retrospectively. The demographic and clinicopathological features of the patients were recorded.Results: Among all patients with primary and secondary SGTs, the median age was 53 years, 54.6% of the patients were men. Patients with primary tumor constituted 96.8% of all cases. Malignancy rate was 14. Parotid gland was the most common location (90%). Nearly half of all primary tumors were diagnosed as pleomorphic adenoma (n=84, 46.9%). Mucoepidermoid carcinoma was the most common malign neoplasm of the parotid gland. There were only six patients (3.2%) that had secondary SGT.Conclusion: Pleomorphic adenoma and mucoepidermoid carcinoma were the most common benign and malign pathologies, respectively. The lowest malignancy rate and the highest rate of warthin tumor of the existing literature were the most conspicuous findings of our study. Although the frequency of the secondary SGTs is low, the possibility of metastasis should be considered especially for the patients above 65 years of age., Amaç: Tükürük bezi tümörleri (TBT’ler) nadir görülen neoplazmlardır, bu nedenle lokal kayıtlar epidemiyolojik bir bakış açısı elde etmek için değerlidir. Bu çalışma, kliniğimizde opere edilen TBT’lerin demografik ve klinikopatolojik özelliklerini belirlemeyi ve bu bulgular ile Türkiye ve tüm dünyadaki çalışmaları karşılaştırmayı amaçlamıştır.Gereç ve yöntemler: 2012 ve 2017 yılları arasında bir üçüncü basamak sağlık merkezinin Kulak Burun Boğaz ve Baş Boyun Cerrahisi Kliniği’nde TBT nedeniyle opere edilen 185 hastanın verileri geriye dönük olarak incelendi. Hastaların demografik ve klinikopatolojik özellikleri kaydedildi.Bulgular: Primer ve sekonder TBT’li tüm hastalar arasında median yaş 53, hastaların %54,6’sı erkekti. Primer tümörlü hastalar tüm vakaların %96,8’ini oluşturmaktaydı. Malignite oranı 14 idi. Parotis bezi en sık lokalizasyondu (%90). Tüm primer tümörlerin yaklaşık yarısına pleomorfik adenom tanısı kondu (n = 84, %46,9). Mukoepidermoid karsinom, parotis bezinin en sık görülen malign neoplazmı idi. Sekonder TBT’si olan sadece altı hasta (%3,2) vardı.Sonuç: Pleomorfik adenom ve mukopidermoid karsinom sırasıyla en sık görülen benign ve malign patolojilerdir. Literatürdeki en düşük malignite oranı ve en yüksek warthin tümörü oranı çalışmamızın en çarpıcı bulgularıdır. İkincil TBT’lerin sıklığının düşük olmasına rağmen, özellikle 65 yaşın üzerindeki hastalarda metastaz olasılığı düşünülmelidir.